Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors

Recombinant adeno-associated virus (rAAV) vectors are among the most effective for gene therapy. A significant advancement in rAAV vector production is developing the triple-plasmid transfection method, which remains the most widely used technique. In this study, we used Expi293F<sup>TM</sup> (Expi293F) and Viral Production Cells 2.0 (VPC2.0 cells) to evaluate various transfection reagents, comparing transgene protein expression levels and intracellular plasmid copy numbers to optimize rAAV production. Our findings indicated that the effectiveness of transfection reagents in promoting higher rAAV production was cell-dependent and that rAAV productivity correlated more with plasmid levels in the cell nucleus than with transgene protein expression levels. Confocal laser microscopy revealed that in cells transfected with the high-yield transfection reagent, a large amount of free plasmid DNA entered the nucleus, whereas the transfection reagents themselves did not. These results provide new insights into the intracellular mechanisms underlying efficient rAAV vector production. Furthermore, identifying transfection reagents that facilitate nuclear plasmid delivery will aid in the selection of optimal reagents for high-yield AAV production.

Authors

Institutions

Publication Details

Journal
Human Gene Therapy
Published
2025-10-16
DOI
https://doi.org/10.1177/10430342251386006
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors

Kazuhisa Uchida, Noriko Hashiba, Kyoko Masumi‐Koizumi, Yuzhe Yuan et al.
Human Gene Therapy
Virus-based gene therapy research
article

Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors

Kazuhisa Uchida, Noriko Hashiba, Kyoko Masumi‐Koizumi, Yuzhe Yuan, Keisuke Yusa, Emi Ito-Kudo
article en

Abstract

Recombinant adeno-associated virus (rAAV) vectors are among the most effective for gene therapy. A significant advancement in rAAV vector production is developing the triple-plasmid transfection method, which remains the most widely used technique. In this study, we used Expi293F<sup>TM</sup> (Expi293F) and Viral Production Cells 2.0 (VPC2.0 cells) to evaluate various transfection reagents, comparing transgene protein expression levels and intracellular plasmid copy numbers to optimize rAAV production. Our findings indicated that the effectiveness of transfection reagents in promoting higher rAAV production was cell-dependent and that rAAV productivity correlated more with plasmid levels in the cell nucleus than with transgene protein expression levels. Confocal laser microscopy revealed that in cells transfected with the high-yield transfection reagent, a large amount of free plasmid DNA entered the nucleus, whereas the transfection reagents themselves did not. These results provide new insights into the intracellular mechanisms underlying efficient rAAV vector production. Furthermore, identifying transfection reagents that facilitate nuclear plasmid delivery will aid in the selection of optimal reagents for high-yield AAV production.

Human Gene TherapyVol. 37(1-2)
Kobe University (JP)
Openalex Percentile: Top 69%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors — Kazuhisa Uchida, Noriko Hashiba, et al. · Human Gene Therapy (2025) | TGRS Research Map | TGRS